SAN CARLOS, Calif., Aug. 21, 2018 /PRNewswire/ -- IncellDx, a leading single cell cancer diagnostics company has launched a complete, pre-optimized kit to identify, enumerate, and quantify the ...
A new blood stabilization method, developed at the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM), significantly prolongs the lifespan of blood samples for microfluidic ...
A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells, living cancer cells carried ...
Slipping by unnoticed is what circulating tumor cells (CTCs) do unless they are subjected to detection, isolation, and capture technology, which is currently wrangling with the task of enumeration, ...
Firms claim microfluidics-based system will provide early indicator of drug response. LabCorp negotiated rights to market cancer diagnostics firm On-Q-ity’s circulating tumor cell (CTC) platform to ...
‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence
WEST LAFAYETTE, Ind. — Accurately diagnosing the spread of cancer often involves painful and invasive biopsy procedures. The use of a “liquid biopsy,” which involves a simple blood draw, has been ...
Stephen Quake, a bioengineer and applied physicist at Stanford University, has always been interested in the interface between physics and biology. During his work at the California Institute of ...
Albert Folch receives funding from the National Institutes of Health and other agencies to fund his microfluidics research and he is the co-founder of OncoFluidics, a startup that aims to to lower the ...
A team of researchers from University of Cincinnati (UC) in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback